We further confirmed the relationship of FTO and KCNE1 in human LAA samples, and their regulatory mechanism in human iPSC‐aCMs, raising the possibility that FTO could be a promising therapeutic target for aging‐induced AF in human. This evidence concerns the gene FTO and atrial fibrillation.